• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium-glucose co-transporter 2 inhibitors?

作者信息

Canepa Marco, Ameri Pietro, Lainscak Mitja

机构信息

Department of Internal Medicine, University of Genova, Genoa, Italy.

Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino - IRCCS Italian Cardiovascular Network, Genoa, Italy.

出版信息

Eur J Heart Fail. 2021 Apr;23(4):644-647. doi: 10.1002/ejhf.2109. Epub 2021 Feb 5.

DOI:10.1002/ejhf.2109
PMID:33502827
Abstract
摘要

相似文献

1
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium-glucose co-transporter 2 inhibitors?慢性阻塞性肺疾病与心力衰竭合并症：钠-葡萄糖协同转运蛋白2抑制剂的下一个前沿领域？
Eur J Heart Fail. 2021 Apr;23(4):644-647. doi: 10.1002/ejhf.2109. Epub 2021 Feb 5.
2
Sodium-glucose co-transporter 2 inhibitors: 'a tale of two sisters', diabetes and heart failure.
Eur J Heart Fail. 2020 Jul;22(7):1259-1262. doi: 10.1002/ejhf.1935. Epub 2020 Jul 14.
3
Sodium-glucose co-transporter 2 inhibitors: strength of evidence for a cardio-renal-metabolic therapy.
Eur J Heart Fail. 2021 Jun;23(6):1009-1011. doi: 10.1002/ejhf.2172. Epub 2021 Apr 5.
4
Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.钠-葡萄糖共转运蛋白 2 抑制剂治疗 2 型糖尿病心力衰竭患者：当前证据与未来方向。
Diabet Med. 2019 Dec;36(12):1550-1561. doi: 10.1111/dme.14140. Epub 2019 Oct 10.
5
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure.欧洲心脏病学会心力衰竭协会关于心力衰竭钠-葡萄糖协同转运蛋白 2 抑制剂的更新。
Eur J Heart Fail. 2020 Nov;22(11):1984-1986. doi: 10.1002/ejhf.2026. Epub 2020 Oct 27.
6
Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes.探索未知：钠-葡萄糖协同转运蛋白2抑制剂在非糖尿病性心力衰竭中的应用
Eur J Heart Fail. 2019 Jul;21(7):874-876. doi: 10.1002/ejhf.1500. Epub 2019 May 21.
7
Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease.重点更新：心力衰竭和/或慢性肾脏病患者的 SGLT2 抑制剂。
Ann Pharmacother. 2021 Feb;55(2):252-260. doi: 10.1177/1060028020934001. Epub 2020 Jun 13.
8
EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction.EMPEROR-Reduced研究：证实钠-葡萄糖协同转运蛋白2抑制剂是射血分数降低的心力衰竭患者的重要治疗方法。
Eur J Heart Fail. 2020 Nov;22(11):1987-1990. doi: 10.1002/ejhf.2006. Epub 2020 Oct 2.
9
Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.钠-葡萄糖协同转运蛋白 2 抑制剂是否通过平衡瘦素的作用来预防射血分数保留的心力衰竭？一个新的假说。
Diabetes Obes Metab. 2018 Jun;20(6):1361-1366. doi: 10.1111/dom.13229. Epub 2018 Feb 20.
10
Comment on Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure.对钠-葡萄糖协同转运蛋白2抑制剂与心力衰竭的评论
Am J Cardiol. 2020 May 15;125(10):1602. doi: 10.1016/j.amjcard.2020.03.001. Epub 2020 Mar 5.

引用本文的文献

1
The Complex Relationship Between Heart Failure and Chronic Obstructive Pulmonary Disease: A Comprehensive Review.心力衰竭与慢性阻塞性肺疾病之间的复杂关系：一项综述
J Clin Med. 2025 Jul 6;14(13):4774. doi: 10.3390/jcm14134774.
2
Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure.慢性阻塞性肺疾病伴/不伴心力衰竭管理护理包的实施
J Clin Med. 2024 Mar 12;13(6):1621. doi: 10.3390/jcm13061621.
3
Impact of COPD and asthma on in-hospital mortality and management of patients with heart failure in England and Wales: an observational analysis.
COPD 和哮喘对英格兰和威尔士心力衰竭住院患者死亡率和治疗的影响：一项观察性分析。
BMJ Open. 2022 Jun 30;12(6):e059122. doi: 10.1136/bmjopen-2021-059122.